Literature DB >> 6227747

Folate antagonists. 20. Synthesis and antitumor and antimalarial properties of trimetrexate and related 6-[(phenylamino)methyl]-2,4-quinazolinediamines.

E F Elslager, J L Johnson, L M Werbel.   

Abstract

A series of 6-[(arylamino)methyl]-2,4-quinazolinediamines have been prepared by catalytic hydrogenation of the requisite 2,4-diamino-6-quinazolinecarbonitriles in the presence of the appropriate benzenamine. Formylation, acetylation, and nitrosation provided N omega derivatives of these compounds. A variety of the compounds exhibited potent antimalarial, antibacterial, and antitumor activity. In particular, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)-amino]methyl]-2, 4-quinazolinediamine (trimetrexate, 15) has shown a broad spectrum of antitumor effects and is undergoing preclinical toxicology evaluation prior to trial in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6227747     DOI: 10.1021/jm00366a018

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Trimetrexate: a new antifol entering clinical trials.

Authors:  P J O'Dwyer; D D Shoemaker; J Plowman; J Cradock; A Grillo-Lopez; B Leyland-Jones
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Skin reactions induced by trimetrexate, an analog of methotrexate.

Authors:  R B Weiss; W D James; W B Major; M B Porter; C J Allegra; G A Curt
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

3.  Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate.

Authors:  V I Polshakov; B Birdsall; T A Frenkiel; A R Gargaro; J Feeney
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

Review 4.  Clinical pharmacokinetics and pharmacology of trimetrexate.

Authors:  J L Marshall; R J DeLap
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

5.  Phase II trial of trimetrexate in advanced esophageal cancer: a southwest oncology group study.

Authors:  T R Fleming; T D Brown; S W Ross; J S Macdonald
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 6.  Biological and biochemical properties of new anticancer folate antagonists.

Authors:  D W Fry; R C Jackson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Antimicrobial effects of new 1-(1,2,4-triazol-1-yl)-acetanilides.

Authors:  S Jantová; D Hudecová; S Stankovský; K Spirková
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

8.  Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.

Authors:  Eunice Nduati; Abdi Diriye; Sheila Ommeh; Leah Mwai; Steven Kiara; Victor Masseno; Gilbert Kokwaro; Alexis Nzila
Journal:  Parasitol Res       Date:  2008-02-09       Impact factor: 2.289

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.